» Articles » PMID: 37537685

Prognostic Implication of Downregulated Exosomal MiRNAs in Patients with Sepsis: a Cross-sectional Study with Bioinformatics Analysis

Overview
Publisher Biomed Central
Specialty Critical Care
Date 2023 Aug 3
PMID 37537685
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the understanding of sepsis-induced extracellular vesicles (EVs), such as exosomes, and their role in intercellular communication during sepsis, little is known about EV contents such as microRNA (miRNA), which modulate important cellular processes contributing to sepsis in body fluids. This study aimed to analyze the differential expression of exosomal miRNAs in plasma samples collected from sepsis patients and healthy controls, and to identify potential miRNA regulatory pathways contributing to sepsis pathogenesis.

Methods: Quantitative real-time PCR-based microarrays were used to profile plasma exosomal miRNA expression levels in 135 patients with sepsis and 11 healthy controls from an ongoing prospective registry of critically ill adult patients admitted to the intensive care unit. The identified exosomal miRNAs were tested in an external validation cohort (35 sepsis patients and 10 healthy controls). And then, functional enrichment analyses of gene ontology, KEGG pathway analysis, and protein-protein interaction network and cluster analyses were performed based on the potential target genes of the grouped miRNAs. Finally, to evaluate the performance of the identified exosomal miRNAs in predicting in-hospital and 90-day mortalities of sepsis patients, receiver operating characteristic curve (ROC) and Kaplan-Meier analyses were performed.

Results: Compared with healthy controls, plasma exosomes from sepsis patients showed significant changes in 25 miRNAs; eight miRNAs were upregulated and 17 downregulated. Additionally, the levels of hsa-let-7f-5p, miR-331-3p miR-301a-3p, and miR-335-5p were significantly lower in sepsis patients than in healthy controls (p < 0.0001). These four miRNAs were confirmed in an external validation cohort. In addition, the most common pathway for these four miRNAs were PI3K-Akt and mitogen-activated protein kinase (MAPK) signaling pathways based on the KEGG analysis. The area under the ROC of hsa-let-7f-5p, miR-331-3p, miR-301a-3p, and miR-335-5p level for in-hospital mortality was 0.913, 0.931, 0.929, and 0.957, respectively (p < 0.001), as confirmed in an external validation cohort. Also, the Kaplan-Meier analysis showed a significant difference in 90-day mortality between sepsis patients with high and low miR-335-5p, miR-301a-3p, hsa-let-7f-5p, and miR-331-3p levels (p < 0.001, log-rank test).

Conclusion: Among the differentially-expressed miRNAs detected in microarrays, the top four downregulated exosomal miRNAs (hsa-let-7f-5p, miR-331-3p miR-301a-3p, and miR-335-5p) were identified as independent prognostic factors for in-hospital and 90-day mortalities among sepsis patients. Bioinformatics analysis demonstrated that these four microRNAs might provide a significant contribution to sepsis pathogenesis through PI3K-Akt and MAPK signaling pathway.

Citing Articles

Study on the diagnostic role of exosome-derived miRNAs in postoperative septic shock and non-septic shock patients.

Garcia-Concejo A, Sanchez-Quiros B, Gomez-Sanchez E, Sanchez-de Prada L, Tamayo-Velasco A, Tovar-Doncel M Crit Care. 2025; 29(1):96.

PMID: 40033446 PMC: 11874436. DOI: 10.1186/s13054-025-05320-y.


Plasma-derived extracellular vesicles prime alveolar macrophages for autophagy and ferroptosis in sepsis-induced acute lung injury.

Ye R, Wei Y, Li J, Zhong Y, Chen X, Li C Mol Med. 2025; 31(1):40.

PMID: 39901167 PMC: 11792199. DOI: 10.1186/s10020-025-01111-x.


Pathologic function and therapeutic potential of extracellular vesicle miRNA in sepsis.

Deng R, Cui X, Zhang R, Liu C, Luo J, Liu L Front Pharmacol. 2025; 15:1452276.

PMID: 39744123 PMC: 11688188. DOI: 10.3389/fphar.2024.1452276.


Identification of key regulatory genes in the pathogenesis of COVID-19 and sepsis: An observational study.

Chen X, Yang F, Luo G Medicine (Baltimore). 2024; 103(22):e38378.

PMID: 39259097 PMC: 11142772. DOI: 10.1097/MD.0000000000038378.


Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis.

Xiao Y, Yuan Y, Hu D, Wang H J Immunol Res. 2024; 2024:4481452.

PMID: 39104595 PMC: 11300089. DOI: 10.1155/2024/4481452.


References
1.
Zhang Y, Liu Y, Liu H, Tang W . Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9:19. PMC: 6377728. DOI: 10.1186/s13578-019-0282-2. View

2.
Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

3.
Im Y, Yoo H, Ko R, Lee J, Park J, Jeon K . Exosomal CD63 in critically ill patients with sepsis. Sci Rep. 2021; 11(1):20300. PMC: 8514522. DOI: 10.1038/s41598-021-99777-w. View

4.
Real J, Ferreira L, Esteves G, Koyama F, Dias M, Bezerra-Neto J . Exosomes from patients with septic shock convey miRNAs related to inflammation and cell cycle regulation: new signaling pathways in sepsis?. Crit Care. 2018; 22(1):68. PMC: 5852953. DOI: 10.1186/s13054-018-2003-3. View

5.
Knaus W, Draper E, Wagner D, Zimmerman J . APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13(10):818-29. View